Filing Details
- Accession Number:
- 0000899243-22-016641
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-04 17:10:57
- Reporting Period:
- 2022-05-02
- Accepted Time:
- 2022-05-04 17:10:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1829069 | Bastiano Sanna | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cell & Genetic Therapies | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-05-02 | 20 | $255.47 | 41,996 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 90 | $257.49 | 41,906 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 43 | $258.46 | 41,863 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 75 | $259.58 | 41,788 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 23 | $260.44 | 41,765 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 65 | $261.79 | 41,700 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-05-02 | 4 | $264.37 | 41,696 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Sanna's company approved trading plan under Rule 10b5-1.
- Dr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $255.47 (range $255.23 to $255.70).
- Open market sales reported on this line occurred at a weighted average price of $257.49 (range $257.05 to $257.87).
- Open market sales reported on this line occurred at a weighted average price of $258.46 (range $258.11 to $258.93).
- Open market sales reported on this line occurred at a weighted average price of $259.58 (range $259.24 to $260.07).
- Open market sales reported on this line occurred at a weighted average price of $260.44 (range $260.35 to $261.31).
- Open market sales reported on this line occurred at a weighted average price of $261.79 (range $261.39 to $262.23).
Billionaire Hedge Funds
